Oruka Therapeutics, Inc.
Ticker: ORKA
| Insider | Title |
|---|---|
| Anders D Hove | Director |
| Arjun Agarwal | SVP, Finance and Treasurer |
| C. Jeffrey Dekker | Chief Financial Officer |
| Cameron Turtle | Director |
| Carl Dambkowski | Director |
| Christopher David Ozeroff | S.V.P., General Counsel |
| Daniel J Mitchell | Director |
| Fund, Lp Funicular | See Footnote 1 |
| Funds Management Llc Fairmount | Director, 10% or greater ownership |
| Funds, Lp Funicular | See Footnote 1, 10% or greater ownership |
| Healthcare Co-invest Iii L.p. Fairmount | Director, 10% or greater ownership |
| Healthcare Fund Ii L.p. Fairmount | Director, 10% or greater ownership |
| Henderson Biotech Innovation Master Fund Ltd Janus | 10% or greater ownership |
| Henderson Group Plc Janus | 10% or greater ownership |
| Jacob Ma-weaver | See footnote 1 |
| James P Flynn | Director |
| Joana Goncalves | Chief Medical Officer |
| Kristine M Ball | Director |
| Lawrence Otto Klein | President and CEO, Director |
| Linda Grais | Director |
| Michael R Bristow | Pres. Chief Executive Offic, Director |
| Paul T Quinlan | General Counsel and Secretary |
| Peter Evan Harwin | Director, 10% or greater ownership |
| Raymond L. Woosley | Director |
| Robert E Conway | Director, Chairman of the Board |
| Samarth Kulkarni | Director |
| Thomas A Keuer | Chief Operating Officer |
| Tomas Kiselak | Director, 10% or greater ownership |